Report finds noncompliance in price reporting

A report from HHS's Office of Inspector General found that in 2008 more than half of drug manufacturers did not fully comply with quarterly requirements to submit drug pricing data to the Centers for Medicare & Medicaid Services. The report also noted that more than 75% of manufacturers did not fully comply with monthly submission requirements. The OIG said CMS took action against some manufacturers that failed to comply with quarterly requirements but took no action against manufacturers that failed to comply with monthly requirements. ...